Mr. Chairman, I rise in order to speak on the amendment offered by Representatives Barton, Meadows and Kuster. FDA Commissioner Gottlieb testified before the Energy and Commerce Committee about the work the agency is doing currently to…

Mr. Chairman, I want to thank the staff who worked so hard on H.R. 6 and the opioid bills, in general. Democrats worked to make H.R. 6 a better bill, even though we have concerns about the overall impact of the opioid package. Mr. Chair, I…

Mr. Chairman, I want to enter into the Record my extended remarks regarding a provision included in H.R. 6 that does not enjoy bipartisan support. Section 301 was passed out of the Energy and Commerce Committee on a party-line vote. Had a…

Mr. Chair, although I am not opposed to the amendment, I ask unanimous consent to claim the time in opposition. The Acting CHAIR. Is there objection to the request of the gentleman from Oregon? There was no objection. The Acting CHAIR. The…

Mr. Chairman, I rise to speak in support of the amendment and to thank my friend from Utah, Mr. Curtis, for his hard work on this very thoughtful piece of legislation. It is important that women who take opioid pain medications are aware…

Mr. Chairman, although I am not opposed to the amendment, I ask unanimous consent to claim time in opposition. The Acting CHAIR. Is there objection to the request of the gentleman from Oregon? There was no objection. The Acting CHAIR. The…

Mr. Chairman, I rise to speak in support of the amendment that requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug. The guidelines would cover dosage safety, standing…

Mr. Chairman, because the gentleman raised the issue of these synthetics on other--we have talked a lot about fentanyl being cut into heroin over the course of this debate over 2 weeks. We haven't talked as much about these synthetics…

Mr. Chairman, although I am not opposed to the amendment, I ask unanimous consent to claim the time in opposition. The Acting CHAIR. Is there objection to the request of the gentleman from Oregon? There was no objection. The Acting CHAIR…

Mr. Chair, I rise to speak in support of this amendment and to thank my friend, Ms. Waters, for her work on this initiative. Before I go through that, I just want to say we are more than happy to team up with the gentlewoman on this issue…

Mr. Speaker, I claim the time in opposition to the motion. The SPEAKER pro tempore. The gentleman from Oregon is recognized for 5 minutes.

Mr. Speaker, like a lot of our work here that has been bipartisan, we would hope, going forward, this, too, could become bipartisan, because we believe that getting prescription drug prices down is essential. The Trump administration…

Mr. Speaker, on that I demand the yeas and nays. The yeas and nays were ordered. The SPEAKER pro tempore. This is a 5-minute vote. The vote was taken by electronic device, and there were--yeas 396, nays 14, not voting 17, as follows: [Roll…

Mr. Chairman, I yield 1 minute to the gentleman from Kentucky (Mr. Guthrie), the vice chairman of the Subcommittee on Health, a great leader on these issues and more.

It is now my great honor, Mr. Chairman, to yield 1 minute to the gentleman from California (Mr. McCarthy), who is the majority leader of the United States House of Representatives. He has been extraordinarily helpful in our efforts to move…

Mr. Chair, I thank my colleague from California for bringing this issue to our attention and helping us help these kids who need this assistance. Mr. Chair, I yield 1 minute to the gentleman from Wisconsin (Mr. Ryan), the Speaker of the…

Mr. Chairman, I want to thank my colleague from California for working with us. We were happy to include his bill in this compilation of legislation. Mr. Chair, I yield 1 minute to the gentleman from Georgia (Mr. Carter), our resident…

Mr. Chair, I yield 1 minute to the gentleman from New Jersey (Mr. Lance), who has been very, very involved in this effort.